Axa S.A. Raises Holdings in Caleres, Inc. (NYSE:CAL)

Axa S.A. lifted its stake in shares of Caleres, Inc. (NYSE:CAL) by 276.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 42,811 shares of the textile maker’s stock after buying an additional 31,449 shares during the quarter. Axa S.A. owned approximately 0.13% of Caleres worth $992,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. Smartleaf Asset Management LLC lifted its stake in Caleres by 254.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,733 shares of the textile maker’s stock worth $40,000 after acquiring an additional 1,244 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of Caleres during the 4th quarter worth $59,000. Lee Danner & Bass Inc. acquired a new position in shares of Caleres during the fourth quarter worth $81,000. Canada Pension Plan Investment Board purchased a new position in Caleres in the fourth quarter valued at $86,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in Caleres in the fourth quarter valued at $149,000. 98.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Caleres news, Director Lori Greeley purchased 9,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 27th. The stock was purchased at an average price of $17.77 per share, for a total transaction of $159,930.00. Following the purchase, the director now directly owns 10,000 shares in the company, valued at approximately $177,700. This trade represents a 900.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 4.10% of the company’s stock.

Analysts Set New Price Targets

Separately, Loop Capital lowered their price objective on Caleres from $17.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 4th.

Caleres Trading Down 4.1 %

Shares of NYSE:CAL opened at $15.04 on Friday. The firm has a 50 day simple moving average of $16.04 and a 200-day simple moving average of $21.09. The company has a market capitalization of $505.52 million, a PE ratio of 3.35 and a beta of 1.11. Caleres, Inc. has a twelve month low of $14.25 and a twelve month high of $44.51.

Caleres (NYSE:CAL) last announced its quarterly earnings results on Thursday, March 20th. The textile maker reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. Caleres had a net margin of 5.69% and a return on equity of 22.71%. The firm had revenue of $639.20 million during the quarter, compared to analysts’ expectations of $645.79 million. During the same period in the previous year, the company earned $0.86 earnings per share. Caleres’s quarterly revenue was down 8.3% compared to the same quarter last year. As a group, equities research analysts predict that Caleres, Inc. will post 3.23 EPS for the current fiscal year.

Caleres Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Thursday, March 27th were paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 1.86%. The ex-dividend date was Thursday, March 27th. Caleres’s dividend payout ratio is currently 9.12%.

Caleres Company Profile

Caleres, Inc engages in the retail and wholesale of footwear business in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr.